Altered responsiveness to TGF-β results in reduced Papss2 expression and alterations in the biomechanical properties of mouse articular cartilage

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Ramaswamy, Girish ^a   Sohn, Philip ^b   Eberhardt, Alan ^a   Serra, Rosa ^b  

^a and Radiation Oncology   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CHONDROITIN 4 SULFATE; GLYCOSAMINOGLYCAN; PHOSPHOADENOSINE PHOSPHOSYNTHETASE 2; SYNTHETASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; MULTIENZYME COMPLEX; PAPS SYNTHETASE; SULFATE ADENYLYLTRANSFERASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BIOMECHANICS; CARTILAGE CELL; CARTILAGE MATRIX; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GENE IDENTIFICATION; JOINT DEGENERATION; MICROARRAY ANALYSIS; MOUSE; MUTATION; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SULFATION; TIBIA; UPREGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CATTLE; CELL CULTURE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BIOMECHANICS; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; MULTIENZYME COMPLEXES; ORGAN CULTURE TECHNIQUES; SULFATE ADENYLYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857760257     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3762     Document Type: Article

References (52)

1. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007, 213:626-634. 10.1002/jcp.21258, 17786965.
2. Seo HS, Serra R. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints. Dev Biol 2007, 310:304-316. 10.1016/j.ydbio.2007.07.040, 2042108, 17822689.
3. van der Kraan PM, Blaney Davidson EN, van den Berg WB. A role for age-related changes in TGFβ signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res Ther 2010, 12:201. 10.1186/ar3173, 2875624, 20156325.
4. Verdier MP, Seité S, Guntzer K, Pujol JP, Boumédiène K. Immunohistochemical analysis of transforming growth factor β isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads. Rheumatol Int 2005, 25:118-124. 10.1007/s00296-003-0409-x, 14618374.
5. Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, van den Berg WB, van der Kraan PM. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 2009, 182:7937-7945. 10.4049/jimmunol.0803991, 19494318.
6. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL. Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 1997, 139:541-552. 10.1083/jcb.139.2.541, 2139797, 9334355.
7. Yang X, Chen L, Xu X, Li C, Huang C, Deng CX. TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 2001, 153:35-46. 10.1083/jcb.153.1.35, 2185521, 11285272.
8. Dabovic B, Chen Y, Colarossi C, Zambuto L, Obata H, Rifkin DB. Bone defects in latent TGF-β binding protein (Ltbp)-3 null mice: a role for Ltbp in TGF-β presentation. J Endocrinol 2002, 175:129-141. 10.1677/joe.0.1750129, 12379497.
9. Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O'Brien T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ, Zuscik MJ, Rosier RN. Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum 2008, 58:3132-3144. 10.1002/art.23946, 2636703, 18821706.
10. Alexopoulos LG, Youn I, Bonaldo P, Guilak F. Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix. Arthritis Rheum 2009, 60:771-779. 10.1002/art.24293, 2724839, 19248115.
11. Knecht S, Vanwanseele B, Stussi E. A review on the mechanical quality of articular cartilage: implications for the diagnosis of osteoarthritis. Clin Biomech (Bristol, Avon) 2006, 21:999-1012.
12. Le NA, Fleming BC. Measuring fixed charge density of goat articular cartilage using indentation methods and biochemical analysis. J Biomech 2008, 41:715-720. 10.1016/j.jbiomech.2007.09.035, 2288547, 17991472.
13. Lu XL, Mow VC. Biomechanics of articular cartilage and determination of material properties. Med Sci Sports Exerc 2008, 40:193-199. 10.1249/mss.0b013e31815cb1fc, 18202585.
14. Venkatachalam KV. Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency. IUBMB Life 2003, 55:1-11.
15. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci 2000, 113:193-205.
16. Ahmad M, Haque MF, Ahmad W, Abbas H, Haque S, Krakow D, Rimoin DL, Lachman RS, Cohn DH. Distinct, autosomal recessive form of spondyloepimetaphyseal dysplasia segregating in an inbred Pakistani kindred. Am J Med Genet 1998, 78:468-473. 10.1002/(SICI)1096-8628(19980806)78:5<468::AID-AJMG13>3.0.CO;2-D, 9714015.
17. Faiyaz ul Haque M, King LM, Krakow D, Cantor RM, Rusiniak ME, Swank RT, Superti-Furga A, Haque S, Abbas H, Ahmad W, Ahmad M, Cohn DH. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat Genet 1998, 20:157-162. 10.1038/2458, 9771708.
18. Kurima K, Warman ML, Krishnan S, Domowicz M, Krueger RC, Deyrup A, Schwartz NB. A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc Natl Acad Sci USA 1998, 95:8681-8685. 10.1073/pnas.95.15.8681, 21136, 9671738.
19. Ford-Hutchinson AF, Ali Z, Seerattan RA, Cooper DM, Hallgrímsson B, Salo PT, Jirik FR. Degenerative knee joint disease in mice lacking 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (Papss2) activity: a putative model of human PAPSS2 deficiency-associated arthrosis. Osteoarthritis Cartilage 2005, 13:418-425. 10.1016/j.joca.2004.12.011, 15882565.
20. Baffi MO, Slattery E, Sohn P, Moses HL, Chytil A, Serra R. Conditional deletion of the TGF-β type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev Biol 2004, 276:124-142. 10.1016/j.ydbio.2004.08.027, 15531369.
21. Sugahara K, Schwartz NB. Defect in 3'-phosphoadenosine 5'-phosphosulfate synthesis in brachymorphic mice. II. Tissue distribution of the defect. Arch Biochem Biophys 1982, 214:602-609. 10.1016/0003-9861(82)90065-0, 6284030.
22. Hyttinen MM, Töyräs J, Lapveteläinen T, Lindblom J, Prockop DJ, Li SW, Arita M, Jurvelin JS, Helminen HJ. Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer. Ann Rheum Dis 2001, 60:262-268. 10.1136/ard.60.3.262, 1753566, 11171689.
23. Roemhildt ML, Coughlin KM, Peura GD, Fleming BC, Beynnon BD. Material properties of articular cartilage in the rabbit tibial plateau. J Biomech 2006, 39:2331-2337. 10.1016/j.jbiomech.2005.07.017, 2933407, 16168420.
24. IHC World: Life Science Information Network. , http://www.ihcworld.com/
25. Scott JE, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions. Histochemie 1965, 5:221-233. 10.1007/BF00306130, 4223499.
26. Taylor JR, Scott JE, Cribb AM, Bosworth TR. Human intervertebral disc acid glycosaminoglycans. J Anat 1992, 180:137-141. 1259617, 1452468.
27. Chen P, Vukicevic S, Sampath TK, Luyten FP. Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1. Biochem Biophys Res Commun 1993, 197:1253-1259. 10.1006/bbrc.1993.2612, 8280141.
28. Luyten FP, Chen P, Paralkar V, Reddi AH. Recombinant bone morphogenetic protein-4, transforming growth factor-β1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp Cell Res 1994, 210:224-229. 10.1006/excr.1994.1033, 8299720.
29. Björnsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 1993, 210:282-291. 10.1006/abio.1993.1197, 8512063.
30. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36. 10.1093/nar/30.9.e36, 113859, 11972351.
31. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14:13-29. 10.1016/j.joca.2005.07.014, 16242352.
32. Niikura T, Reddi AH. Differential regulation of lubricin/superficial zone protein by transforming growth factor β/bone morphogenetic protein superfamily members in articular chondrocytes and synoviocytes. Arthritis Rheum 2007, 56:2312-2321. 10.1002/art.22659, 17599751.
33. Alvarez J, Sohn P, Zeng X, Doetschman T, Robbins DJ, Serra R. TGFβ2 mediates the effects of Hedgehog on hypertrophic differentiation and PTHrP expression. Development 2002, 129:1913-1924.
34. Ohno S, Tanaka N, Ueki M, Honda K, Tanimoto K, Yoneno K, Ohno-Nakahara M, Fujimoto K, Kato Y, Tanne K. Mechanical regulation of terminal chondrocyte differentiation via RGD-CAP/βig-h3 induced by TGF-β. Connect Tissue Res 2005, 46:227-234. 10.1080/03008200500346111, 16546826.
35. Brunschwig EB, Wilson K, Mack D, Dawson D, Lawrence E, Willson JK, Lu S, Nosrati A, Rerko RM, Swinler S, Beard L, Lutterbaugh JD, Willis J, Platzer P, Markowitz S. PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res 2003, 63:1568-1575.
36. Sohn P, Cox M, Chen D, Serra R. Molecular profiling of the developing mouse axial skeleton: a role for Tgfbr2 in the development of the intervertebral disc. BMC Dev Biol 2010, 10:29. 10.1186/1471-213X-10-29, 2848151, 20214815.
37. Sugahara K, Schwartz NB. Defect in 3'-phosphoadenosine 5'-phosphosulfate synthesis in brachymorphic mice: I. Characterization of the defect. Arch Biochem Biophys 1982, 214:589-601. 10.1016/0003-9861(82)90064-9, 6284029.
38. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984, 307:650-652. 10.1038/307650a0, 6420711.
39. Caterson B, Christner JE, Baker JR, Couchman JR. Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc 1985, 44:386-393.
40. Cortes M, Baria AT, Schwartz NB. Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate. Development 2009, 136:1697-1706. 10.1242/dev.030742, 2673757, 19369399.
41. Mak AF, Lai WM, Mow VC. Biphasic indentation of articular cartilage: I. Theoretical analysis. J Biomech 1987, 20:703-714. 10.1016/0021-9290(87)90036-4, 3654668.
42. Lu XL, Miller C, Chen FH, Guo XE, Mow VC. The generalized triphasic correspondence principle for simultaneous determination of the mechanical properties and proteoglycan content of articular cartilage by indentation. J Biomech 2007, 40:2434-2441. 10.1016/j.jbiomech.2006.11.015, 17222852.
43. Alnouti Y, Klaassen CD. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther 2008, 324:612-621.
44. Stelzer C, Brimmer A, Hermanns P, Zabel B, Dietz UH. Expression profile of Papss2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo. Dev Dyn 2007, 236:1313-1318. 10.1002/dvdy.21137, 17436279.
45. Klüppel M, Wight TN, Chan C, Hinek A, Wrana JL. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development 2005, 132:3989-4003. 10.1242/dev.01948, 16079159.
46. Bonafé L, Hästbacka J, de la Chapelle A, Campos-Xavier AB, Chiesa C, Forlino A, Superti-Furga A, Rossi A. A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. J Med Genet 2008, 45:827-831. 10.1136/jmg.2007.057158, 18708426.
47. Forlino A, Piazza R, Tiveron C, Della Torre S, Tatangelo L, Bonafé L, Gualeni B, Romano A, Pecora F, Superti-Furga A, Cetta G, Rossi A. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum Mol Genet 2005, 14:859-871. 10.1093/hmg/ddi079, 15703192.
48. Otsuki S, Hanson SR, Miyaki S, Grogan SP, Kinoshita M, Asahara H, Wong CH, Lotz MK. Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci USA 2010, 107:10202-10207. 10.1073/pnas.0913897107, 2890424, 20479257.
49. Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AF, van der Sluijs HA, Pruijs HE, TeKoppele JM. Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA 1999, 96:1054-1058. 10.1073/pnas.96.3.1054, 15349, 9927692.
50. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, Brinckmann J, Abraham DJ, Black CM, Verzijl N, DeGroot J, Hanemaaijer R, TeKoppele JM, Huizinga TW, Bank RA. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003, 278:40967-40972. 10.1074/jbc.M307380200, 12881513.
51. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005, 115:622-631. 548698, 15719068.
52. Coles JM, Zhang L, Blum JJ, Warman ML, Jay GD, Guilak F, Zauscher S. Loss of cartilage structure, stiffness, and frictional properties in mice lacking PRG4. Arthritis Rheum 2010, 62:1666-1674. 10.1002/art.27436, 2943386,2943386, 20191580.